HYDROCORTISONE SODIUM PHOSPHATE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for hydrocortisone sodium phosphate and what is the scope of freedom to operate?
Hydrocortisone sodium phosphate
is the generic ingredient in one branded drug marketed by Merck and is included in one NDA. Additional information is available in the individual branded drug profile pages.There are two drug master file entries for hydrocortisone sodium phosphate.
Summary for HYDROCORTISONE SODIUM PHOSPHATE
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Drug Master File Entries: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 51 |
Clinical Trials: | 6 |
Patent Applications: | 4,793 |
Formulation / Manufacturing: | see details |
DailyMed Link: | HYDROCORTISONE SODIUM PHOSPHATE at DailyMed |
Recent Clinical Trials for HYDROCORTISONE SODIUM PHOSPHATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Servier | Phase 1 |
AbbVie | Phase 1 |
Andrew E. Place | Phase 1 |
US Patents and Regulatory Information for HYDROCORTISONE SODIUM PHOSPHATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Merck | HYDROCORTONE | hydrocortisone sodium phosphate | INJECTABLE;INJECTION | 012052-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |